Back to Clinical Trials Overview

Your search for "Depression" returned 22 results:


Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression
Principal Investigator(s): Dan Iosifescu

A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients with Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Principal Investigator(s): Dan Iosifescu, MD

Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)
Principal Investigator(s): Dan Iosifescu

The Neuroimmunology of Anhedonia
Principal Investigator(s): Gabbay, Vilma

Ketamine Plus Lithium as a Novel Pharmacotherapeutic Strategy in Treatment Resistant Depression
Principal Investigator(s): James Murrough, MD

Intravenous (IV) Ketamine in Treatment-Resistant Bipolar Depression (TRBD)
Principal Investigator(s): Murrough, James

Cognitive Training for Mood and Anxiety Disorders
Principal Investigator(s): Brian Iacoviello

Cognitive Training in Depression
Principal Investigator(s): Brian Iacoviello

A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-Coil deep Transcranial Magnetic Stimulation (TMS) in conjunction with mood stabilizers in Subjects with Bipolar Depression
Principal Investigator(s): Dan Iosifescu

Neuroinflammation and Positive Valence System Deficits in Adolescents
Principal Investigator(s): Vilma Gabbay

A Clinical Pilot Study Examining Bilateral Inhibition of the Lateral Habenula as a Target for Deep Brain Stimulation in Intractable Depression
Principal Investigator(s): Wayne Goodman

Dopamine and Motivation in Depression
Principal Investigator(s): Dan Iosifescu

Cognitive Training for Depression
Principal Investigator(s): Brian M. Iacoviello

Targeting the NMDA Glutamate Receptor as a Novel Antidepressant Strategy: A Pilot Clinical Trial of Nuedexta in Treatment-Resistant Major Depression
Principal Investigator(s): James Murrough

A Phase 2, Multicenter, Double-blind, Parallel-group, Randomized, Placebo-controlled, Forced-dose Titration, Dose-ranging Efficacy and Safety Study of SPD489 in Combination with an Antidepressant in the Treatment of Adults with Major Depressive Disorder with Inadequate Response to Prospective Treatment with an Antidepressant
Principal Investigator(s): Dan Iosifescu, MD

A Proof-Of-Concept Clinical Trial of a Novel KCNQ Potentiator in Major Depressive Disorder
Principal Investigator(s): James Murrough

Double-blind, Randomized Study of Extended-release Quetiapine Fumarate (Seroquel XR) in the Treatment of Patients with Comorbid Depression and Anxiety Disorder
Principal Investigator(s): Hirschowitz, Jack

Evaluation of Low Emission Neosync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter Randomized, Double-Blind, Sham-Controlled Trial
Principal Investigator(s): Dan Iosifescu, MD

An fMRI Study of Ketamine in Treatment-Resistant Depression
Principal Investigator(s): James Murrough

Minocycline for Bipolar Disorder
Principal Investigator(s): Dan Iosifescu, MD

Ketamine as a Rapid Treatment for Post-Traumatic Stress
Principal Investigator(s): Feder, Adriana

Screening for Depression in Patients with Multiple Sclerosis
Principal Investigator(s): Ben-Zacharia, Aliza